Coston McIsaac & Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24K Buy
287
+67
+30% +$5.4K ﹤0.01% 450
2026
Q1
$15K Hold
220
﹤0.01% 516
2025
Q4
$17K Hold
220
﹤0.01% 490
2025
Q3
$18K Buy
220
+39
+22% +$3.07K ﹤0.01% 466
2025
Q2
$14K Hold
181
﹤0.01% 479
2025
Q1
$14K Hold
181
﹤0.01% 453
2024
Q4
$14K Hold
181
﹤0.01% 442
2024
Q3
$14K Hold
181
﹤0.01% 444
2024
Q2
$12K Sell
181
-123
-40% -$8.78K ﹤0.01% 448
2024
Q1
$22K Buy
304
+135
+80% +$9.41K 0.01% 374
2023
Q4
$11K Sell
169
-88
-34% -$5.51K ﹤0.01% 463
2023
Q3
$16K Hold
257
0.01% 408
2023
Q2
$14K Hold
257
﹤0.01% 458
2023
Q1
$14K Hold
257
0.01% 459
2022
Q4
$18K Hold
257
0.01% 417
2022
Q3
$15K Hold
257
0.01% 376
2022
Q2
$16K Buy
+257
New +$17K 0.01% 234

Other funds holding MET

Coston McIsaac & Partners's MET Position: Q2 2026 in Review

Coston McIsaac & Partners increased its MetLife (MET) stake by 30% in Q2 2026, buying an estimated $5.4K and bringing the position to 287 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #450.

Coston McIsaac & Partners first reported a position in MET in Q2 2022 and has held it in 17 quarters since. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Coston McIsaac & Partners held 287 shares of MetLife worth $24K as of Q2 2026.
  • Coston McIsaac & Partners bought 67 MetLife shares in Q2 2026, an estimated $5.4K.
  • MetLife made up ﹤0.01% of Coston McIsaac & Partners's portfolio in Q2 2026, its #450 holding.
  • Coston McIsaac & Partners first reported a position in MetLife in Q2 2022 and has held it in 17 quarters since.
  • 1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.